EPO Oppositions: Top Tips for Success

ARTICLE SUMMARY

A European Patent Office (EPO) Patent opposition is the legal process that allows anyone to challenge the validity of a EPO patent in all the territories where it is in force in a single action by filing an opposition against its grant on the basis of novelty, inventive step, industrial applicability, insufficiency and/or added matter.

authors
Related Services
Related Industries

A European Patent Office (EPO) Patent opposition is the legal process that allows anyone to challenge the validity of a EPO patent in all the territories where it is in force in a single action by filing an opposition against its grant on the basis of novelty, inventive step, industrial applicability, insufficiency and/or added matter.

The benefit of a successful opposition is simple. It could result in the complete revocation (cancellation) or limitation of a competitor patent in every state or territory covered by the patent, protecting your freedom to operate. It is therefore a cost-effective way to address infringement risk simultaneously in several markets. These benefits need to be balanced against the disadvantages of choosing to file an EPO opposition over national litigation and/or a UPC revocation action.

In this paper we share some of the experience and expertise the EPO oppositions and appeals specialists in our patent team have amassed from both perspectives: (i) effectively opposing a competitor’s patent and (ii) ensuring that defence against a potential opposition is as robust as possible.

Download White Paper

Discover how you can maximise the commercial and strategic value of your patent portfolio.

Thank you.
Your details have been submitted.
Download
Oops! Something went wrong while submitting the form.

Related News

Potter Clarkson launches dedicated women’s health & femtech team

Potter Clarkson launches dedicated women’s health & femtech team

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

Drug discovery in space: How microgravity is transforming pharmaceutical innovation

EU AI Act Article 50: New AI transparency rules

EU AI Act Article 50: New AI transparency rules

Priority patent applications for biotech and chemistry startups

Priority patent applications for biotech and chemistry startups

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

The deal killers investors often find too late: An IP lawyer’s guide to investor readiness

HPV-positive oropharyngeal cancer: prevention to precision treatment

HPV-positive oropharyngeal cancer: prevention to precision treatment

Unlocking the future of cleantech

Unlocking the future of cleantech

Winning at the EPO: Proven specialists in EPO oppositions

Winning at the EPO: Proven specialists in EPO oppositions

See All News
No items found.